Otto Simonsson

1.4k total citations · 2 hit papers
45 papers, 731 citations indexed

About

Otto Simonsson is a scholar working on Clinical Psychology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Otto Simonsson has authored 45 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Clinical Psychology, 15 papers in Organic Chemistry and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Otto Simonsson's work include Psychedelics and Drug Studies (31 papers), Chemical synthesis and alkaloids (15 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Otto Simonsson is often cited by papers focused on Psychedelics and Drug Studies (31 papers), Chemical synthesis and alkaloids (15 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Otto Simonsson collaborates with scholars based in Sweden, United States and United Kingdom. Otto Simonsson's co-authors include Simon B. Goldberg, Peter S. Hendricks, Walter Osika, Stephen D. Fisher, John Torous, Sin U Lam, Richard Chambers, Shufang Sun, James Sexton and Robin Carhart‐Harris and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Otto Simonsson

43 papers receiving 720 citations

Hit Papers

Mobile phone-based interventions for mental health: A sys... 2022 2026 2023 2024 2022 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Otto Simonsson Sweden 15 578 187 154 150 77 45 731
Paul Liknaitzky Australia 12 278 0.5× 122 0.7× 84 0.5× 90 0.6× 72 0.9× 31 463
Christopher B. Thorne United States 7 329 0.6× 134 0.7× 66 0.4× 129 0.9× 49 0.6× 11 477
Henrik Jungaberle Germany 16 664 1.1× 358 1.9× 62 0.4× 219 1.5× 30 0.4× 36 857
Matthias Forstmann Switzerland 12 323 0.6× 127 0.7× 58 0.4× 65 0.4× 71 0.9× 22 660
Matthew M. Yalch United States 16 995 1.7× 159 0.9× 120 0.8× 92 0.6× 263 3.4× 83 1.3k
Larissa J. Maier Switzerland 18 285 0.5× 62 0.3× 122 0.8× 76 0.5× 40 0.5× 61 1.0k
Brian T. Pace United States 13 591 1.0× 95 0.5× 151 1.0× 65 0.4× 170 2.2× 22 909
Geoff J. Bathje United States 8 367 0.6× 120 0.6× 34 0.2× 64 0.4× 23 0.3× 10 480
Kirstie Soar United Kingdom 13 225 0.4× 51 0.3× 203 1.3× 128 0.9× 42 0.5× 24 1.0k
Lisa Evans United States 10 769 1.3× 259 1.4× 24 0.2× 190 1.3× 36 0.5× 15 1.0k

Countries citing papers authored by Otto Simonsson

Since Specialization
Citations

This map shows the geographic impact of Otto Simonsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Simonsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Simonsson more than expected).

Fields of papers citing papers by Otto Simonsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otto Simonsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Simonsson. The network helps show where Otto Simonsson may publish in the future.

Co-authorship network of co-authors of Otto Simonsson

This figure shows the co-authorship network connecting the top 25 collaborators of Otto Simonsson. A scholar is included among the top collaborators of Otto Simonsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otto Simonsson. Otto Simonsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simonsson, Otto, Sankalp Chaturvedi, Peter S. Hendricks, et al.. (2025). Associations between psychedelic-related and meditation-related variables: A longitudinal study. Journal of Psychiatric Research. 184. 457–463.
3.
Simonsson, Otto, Simon B. Goldberg, Walter Osika, et al.. (2025). Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms. Psychological Medicine. 55. e99–e99. 5 indexed citations
4.
Goldberg, Simon B., Jacob T.N. Young, John J. Curtin, et al.. (2025). Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors. PLoS ONE. 20(2). e0310160–e0310160. 1 indexed citations
5.
Sacchet, Matthew D., et al.. (2024). Development of a digital intervention for psychedelic preparation (DIPP). Scientific Reports. 14(1). 4072–4072. 5 indexed citations
6.
7.
Riordan, Kevin M., Otto Simonsson, Corrina Frye, et al.. (2024). How often should I meditate? A randomized trial examining the role of meditation frequency when total amount of meditation is held constant.. Journal of Counseling Psychology. 71(2). 104–114. 6 indexed citations
8.
Simonsson, Otto, et al.. (2024). Psychedelic and MDMA-Related Adverse Effects—A Call for Action. JAMA Health Forum. 5(11). e243630–e243630. 5 indexed citations
9.
Simonsson, Otto, Miriam A. Mosing, Walter Osika, et al.. (2024). Adolescent Psychedelic Use and Psychotic or Manic Symptoms. JAMA Psychiatry. 81(6). 579–579. 16 indexed citations
10.
Riordan, Kevin M., Scott A. Baldwin, Otto Simonsson, et al.. (2024). Is informal practice associated with outcomes in loving-kindness and compassion training? Evidence from pre-post and daily diary assessments. Behaviour Research and Therapy. 177. 104537–104537. 4 indexed citations
11.
Bradley, Melissa A., Daniel Grossman, Otto Simonsson, Heith Copes, & Peter S. Hendricks. (2024). Rural‐urban divide in risk perception of LSD: Implications for psychedelic‐assisted therapy. The Journal of Rural Health. 41(1). e12906–e12906.
12.
Chambers, Richard, et al.. (2023). Psychedelic-Assisted Psychotherapy and Mindfulness-Based Cognitive Therapy: Potential Synergies. Mindfulness. 14(9). 2111–2123. 4 indexed citations
13.
Simonsson, Otto, Per Carlbring, Robin Carhart‐Harris, et al.. (2023). Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis. Psychiatry Research. 327. 115349–115349. 14 indexed citations
14.
Simonsson, Otto, et al.. (2023). Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom. Psychological Medicine. 54(6). 1228–1234. 9 indexed citations
15.
Hendricks, Peter S., et al.. (2022). Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample. Journal of Psychopharmacology. 36(10). 1129–1135. 4 indexed citations
16.
Osika, Walter, Christina Dalman, Otto Simonsson, et al.. (2022). Effects of the COVID-19 pandemic and previous pandemics, epidemics and economic crises on mental health: systematic review. BJPsych Open. 8(6). e181–e181. 14 indexed citations
17.
Goldberg, Simon B., Sin U Lam, Otto Simonsson, John Torous, & Shufang Sun. (2022). Mobile phone-based interventions for mental health: A systematic meta-review of 14 meta-analyses of randomized controlled trials. SHILAP Revista de lepidopterología. 1(1). e0000002–e0000002. 137 indexed citations breakdown →
18.
Simonsson, Otto, Simon B. Goldberg, Richard Chambers, et al.. (2022). Prevalence and associations of classic psychedelic-related seizures in a population-based sample. Drug and Alcohol Dependence. 239. 109586–109586. 13 indexed citations
19.
Simonsson, Otto, et al.. (2021). Effects of an eight-week, online mindfulness program on anxiety and depression in university students during COVID-19: A randomized controlled trial. Psychiatry Research. 305. 114222–114222. 57 indexed citations
20.
Simonsson, Otto, James Sexton, & Peter S. Hendricks. (2021). Associations between lifetime classic psychedelic use and markers of physical health. Journal of Psychopharmacology. 35(4). 447–452. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026